Thomas Stankovich

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Clemente, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Thomas Stankovich
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas Stankovich

Form 4 holding Chief Financial Officer

ReShape Lifesciences Inc.

Security class
Common Stock, $0.001 par value per share
Shares / value
22,949
Estimated value
$6,196
Report date
25 Oct 2023
Price
$0.2700
Ownership
Direct
Form 4 holding Chief Financial Officer

ReShape Lifesciences Inc.

Security class
Common Stock, $0.001 par value per share
Shares / value
22,777
Estimated value
$5,694
Report date
31 May 2024
Price
$0.2500
Ownership
Direct
Form 4 holding Chief Financial Officer

ReShape Lifesciences Inc.

Security class
Common Stock, $0.001 par value per share
Shares / value
0
Estimated value
Report date
15 Jun 2021
Price
Ownership
Direct

Insider Reports Filed by Thomas Stankovich

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .